Related Experiment Video

Updated: Jun 6, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

Non-Alcoholic Steatohepatitis in Myotonic Dystrophy: DMPK Gene Mutation, Insulin Resistance and Development of

Rishi R Bhardwaj1, Andrea Duchini

  • 1Department of Medicine, Weill-Cornell Medical College, The Methodist Hospital, Houston, Tex., USA.

Case Reports in Gastroenterology
|November 25, 2010
PubMed

Insights

Myotonic dystrophy patients may develop non-alcoholic steatohepatitis due to a defective insulin receptor. Further research is needed to understand this link and its implications for patient care.

Area of Science:

  • Genetics
  • Metabolic Disorders
  • Hepatology

Background:

  • Myotonic dystrophy is a genetic disorder caused by repeat expansion mutations in the dystrophia myotonica protein kinase (DMPK) gene.
  • This genetic defect leads to a dysfunctional muscular insulin receptor and subsequent insulin resistance.
  • Insulin resistance is a known risk factor for various metabolic complications, including liver disease.

Observation:

  • A case study of a patient with myotonic dystrophy is presented.
  • The patient was diagnosed with biopsy-proven non-alcoholic steatohepatitis (NASH).
  • This observation suggests a potential link between myotonic dystrophy and the development of NASH.

Findings:

  • Myotonic dystrophy is associated with a defective muscular insulin receptor and insulin resistance.
  • The presented case demonstrates the occurrence of non-alcoholic steatohepatitis in a patient with myotonic dystrophy.
  • This finding indicates a possible predisposition to steatohepatitis in individuals with this genetic disorder.

Implications:

  • Patients with myotonic dystrophy may be at an increased risk for developing non-alcoholic steatohepatitis.
  • The underlying mechanisms connecting the defective insulin receptor in myotonic dystrophy to NASH require further investigation.
  • Understanding this relationship could lead to improved screening and management strategies for metabolic complications in myotonic dystrophy patients.

More Related Videos

Exon Skipping in Directly Reprogrammed Myotubes Obtained from Human Urine-Derived Cells06:20

Exon Skipping in Directly Reprogrammed Myotubes Obtained from Human Urine-Derived Cells

Published on: May 7, 2020

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies14:10

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies

Published on: January 31, 2013

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...